Insider Holders & Insider Ownership - Aileron Therapeutics Inc. (ALRN)

List of insiders holdings for Aileron Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
10% Owner
2024-06-17 19:03:291,746,549
0
1,746,549Form 4
APPLE TREE PARTNERS II LP
10% Owner
2018-07-10 16:26:251,380,241
0
1,380,241Form 4
Novartis Bioventures Ltd
NOVARTIS AG
10% Owner
2020-04-16 07:28:291,199,904
0
1,199,904Form 13D
LV Management Group LLC
Lilly Ventures Fund I LLC
Torres S. Edward
Hall Steven Edward
Former 10% owner
2019-08-13 17:00:231,094,987
0
1,094,987Form 13D
EXCEL MEDICAL FUND LP
Gullans Steven R. Ph.D.
Blume Frederick R.
Enriquez Juan
Excel Medical Ventures LLC
10% Owner
2017-07-13 17:01:031,016,100
0
1,016,100Form 13D
Satter Muneer A
See Remarks
2024-04-16 17:16:57830,466
0
830,466Form 13D
CVF LLC
10% Owner
2017-07-05 20:26:00716,180
0
716,180Form 4
ROCHE HOLDING LTD
ROCHE FINANCE LTD
10% Owner
2017-07-05 20:27:55702,363
0
702,363Form 4
Apple Tree Partners II - Annex L.P.
10% Owner
2018-07-10 16:27:51655,797
0
655,797Form 4
KCK LTD.
10% Owner
2017-07-05 20:28:38646,817
0
646,817Form 4
AJU IB Investment Co. Ltd.
10% Owner
2017-07-07 19:13:330
517,558
517,558Form 4
GLAXOSMITHKLINE PLC
10% Owner
2020-02-14 16:38:33504,926
0
504,926Form 13D
Sigma Emerging Markets Ltd.
10% Owner
2017-07-06 18:25:03423,086
0
423,086Form 4
Wanstall Rick
See Remarks
2022-03-30 20:32:10393,000
0
393,000Form 4/A
Garner Charles
Senior Vice President, Finance
2024-04-02 18:10:42375,347
0
375,347Form 3
Annis Allen
SVP, Research
2022-03-30 20:31:54313,000
0
313,000Form 4/A
Gregory Kathryn
SVP, Chief Business Officer
2020-02-04 16:30:40185,000
0
185,000Form 4
Yanchik Joseph A. III
See Remarks
2017-07-27 18:35:57157,449
0
157,449Form 4
Dougherty Donald
SVP & Chief Financial Officer
2019-04-17 18:44:47150,000
0
150,000Form 4
Vukovic Vojo
Chief Medical Officer
2022-03-30 20:32:28150,000
0
150,000Form 4/A
Platt Jon B.
10% Owner
2017-07-05 20:28:2790,318
0
90,318Form 4
Morrison Jodie Pope
Director
2022-06-17 17:22:1954,500
0
54,500Form 4
MCKEE WILLIAM
Director
2022-06-17 17:18:2754,500
0
54,500Form 4
Sigal Nolan Howard
Director
2022-06-17 17:12:3254,500
0
54,500Form 4
Bailey Jeffrey Allen
Director
2022-06-17 17:10:4954,500
0
54,500Form 4
Nelson Kira
See Remarks
2017-07-27 18:42:2036,844
0
36,844Form 4
VON RICKENBACH JOSEF H
Director
2024-12-06 16:34:5835,000
0
35,000Form 4
Aivado Manuel
Director
2024-12-06 16:41:0235,000
0
35,000Form 4
Ambros Reinhard J.
Director
2024-12-06 16:38:2335,000
0
35,000Form 4
Musso Alan A
Director
2024-12-06 16:32:4835,000
0
35,000Form 4
Fairey William
Director
2024-12-06 16:35:0435,000
0
35,000Form 4
MCARTHUR JOHN H
Director
2019-06-21 16:07:5525,000
0
25,000Form 4
Gallagher Brian M. Jr.
Director
2017-07-27 18:27:5120,000
0
20,000Form 4
LONGENECKER JOHN P PHD
President and CEO
2018-08-14 19:38:2410,000
0
10,000Form 4
Shanafelt Armen
Director
2018-06-25 18:25:4910,000
0
10,000Form 4
Winder Caleb Maxfield
Director
2018-06-25 18:13:4710,000
0
10,000Form 4
WINDSOR JAMES BRIAN
President and CEO
2024-12-09 16:09:307,122
386
7,508Form 4
Cunningham Timothy M.
See Remarks
2024-05-16 17:19:290
0
0Form 3
Drexler Susan L.
See Remarks
2022-06-17 17:12:170
0
0Form 3
Kapnick Scott
Director
10% Owner
2024-02-05 13:20:210
0
0Form 13G